Compare RTX & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RTX | SYK |
|---|---|---|
| Founded | 1934 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.3B | 141.2B |
| IPO Year | N/A | N/A |
| Metric | RTX | SYK |
|---|---|---|
| Price | $180.95 | $354.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 15 |
| Target Price | $177.57 | ★ $431.57 |
| AVG Volume (30 Days) | ★ 4.9M | 1.6M |
| Earning Date | 01-27-2026 | 01-27-2026 |
| Dividend Yield | ★ 1.53% | 1.00% |
| EPS Growth | ★ 38.64 | N/A |
| EPS | 4.87 | ★ 7.61 |
| Revenue | ★ $85,988,000,000.00 | $24,381,000,000.00 |
| Revenue This Year | $8.82 | $12.01 |
| Revenue Next Year | $6.17 | $8.59 |
| P/E Ratio | ★ $36.61 | $46.39 |
| Revenue Growth | 8.79 | ★ 10.95 |
| 52 Week Low | $112.27 | $329.16 |
| 52 Week High | $182.28 | $406.19 |
| Indicator | RTX | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 61.87 | 43.82 |
| Support Level | $176.54 | $349.55 |
| Resistance Level | $182.28 | $359.81 |
| Average True Range (ATR) | 3.35 | 6.61 |
| MACD | 0.75 | -0.44 |
| Stochastic Oscillator | 91.99 | 30.94 |
RTX is an aerospace and defense manufacturer formed from the merger of United Technologies and Raytheon, with roughly equal exposure across three segments, mostly as a supplier to commercial aerospace and to the defense market: Collins Aerospace, a diversified aerospace supplier; Pratt & Whitney, a commercial and military aircraft engine manufacturer; and Raytheon, a defense prime contractor providing a mix of missiles, missile defense systems, sensors, hardware, and communications technology to the military.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.